Moderna's Early Vaccine Results

Posted on AllSides May 21st, 2020

This Abridge News topic aggregates four unique arguments on different sides of the debate. Here are the quick facts to get you started:


  • On Monday, biotech company Moderna Therapeutics announced in a press release "positive" interim phase 1 data for a COVID-19 vaccine trial. Moderna's stock valuation subsequently surged.
  • The company only disclosed information from eight of 45 human subjects, leaving many of the results unknown.
  • Many scientific experts have questioned the optimistic press release, citing the small sample size of these results and lack of supporting scientific
  • ...
Read full story

Abridge News

AllSides Media Bias Rating: Mixed
AllSides Media Bias Rating: Mixed
See full bias rating for Abridge News
Learn about media bias

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right